These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 3486634

  • 1. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K, Matsuoka H, Murakami T, Fujimoto T, Takayanagi F, Sawai K, Niwa J, Hara K.
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [Abstract] [Full Text] [Related]

  • 2. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H, Kosloff C, Nirenberg A, Mehta BM, Huvos AG, Rosen G.
    Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
    [Abstract] [Full Text] [Related]

  • 3. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N, Carrasco H, Raymond K, Ayala A, Eftekhari F.
    Cancer; 2002 Nov 15; 95(10):2202-10. PubMed ID: 12412175
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preoperative administration of high-dose methotrexate for osteosarcoma.
    Chan KW, Knowling MA, Duncan CP, Morton KS.
    Can J Surg; 1984 May 15; 27(3):305-7, 309. PubMed ID: 6586272
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The results of using high-dose methotrexate in treating osteogenic sarcoma].
    Perevodchikova NI, Eremina LA, Manziuk LV, Siniukov PA, Fedenko AN, Singin AS, Moldovanova LK.
    Vopr Onkol; 1990 May 15; 36(6):667-71. PubMed ID: 2378085
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant therapy for osteosarcoma: preoperative and postoperative treatment.
    Eilber FR, Grant T, Morton DL.
    Cancer Treat Rep; 1978 Feb 15; 62(2):213-6. PubMed ID: 346209
    [Abstract] [Full Text] [Related]

  • 15. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).
    Rosen G, Nirenberg A, Caparros B, Juergens H, Kosloff C, Mehta BM, Marcove RC, Huvos AG.
    Natl Cancer Inst Monogr; 1981 Apr 15; (56):213-20. PubMed ID: 6946291
    [Abstract] [Full Text] [Related]

  • 16. Effects of high-dose methotrexate and vincristine on ovarian and testicular functions in patients undergoing postoperative adjuvant treatment of osteosarcoma.
    Shamberger RC, Rosenberg SA, Seipp CA, Sherins RJ.
    Cancer Treat Rep; 1981 Apr 15; 65(9-10):739-46. PubMed ID: 6791818
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcoma.
    Cotter SM, Parker LM.
    Am J Vet Res; 1978 Dec 15; 39(12):1943-5. PubMed ID: 312044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.